Welcome to our dedicated page for 3M CO SEC filings (Ticker: MMM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on 3M CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into 3M CO's regulatory disclosures and financial reporting.
3M Company announced that Jennifer W. Rumsey has been elected to its Board of Directors, effective June 5, 2026. She will also serve on the Board’s Science, Technology and Sustainability Committee.
Rumsey is Chair and Chief Executive Officer of Cummins Inc. and brings global industrial technology and engineering experience to support 3M’s strategic priorities and long-term value goals.
3M Company reported the results of its shareholder votes, including the election of its board and key annual proposals. Each listed director nominee, such as David P. Bozeman and Thomas "Tony" K. Brown, received several hundred million votes in favor, with smaller numbers against or abstaining and 71,690,731 broker non-votes per nominee.
Shareholders ratified PricewaterhouseCoopers LLP as 3M’s independent registered public accounting firm for 2026, with 412,885,060 votes for, 21,557,112 against and 1,652,401 abstentions. Investors also approved, on an advisory basis, the compensation of the company’s named executive officers, with 342,396,161 votes for and 19,808,604 against, plus 2,199,077 abstentions and 71,690,731 broker non-votes.
3M CO non-employee director Thomas W. Sweet reported an indirect compensation-related acquisition of common stock equivalents. On 2026-05-12, an affiliated corporation received 1,360.402 common stock equivalent shares at $143.34 per share under 3M's Compensation Plan for Non-Employee Directors, bringing its indirect holdings to 5,795.588 shares. The filing notes these are deferred dividend reinvestment and deferred compensation shares, and that the director has no voting or investment power over this common stock equivalents account.
3M director Suzan Kereere received a stock grant of 1,360.402 shares of 3M common stock at $143.34 per share. This compensation-related award increased her direct holdings to 6,422.491 shares. A separate entry reports 1,740.410 shares held indirectly by a corporation.
According to a footnote, the reported holdings include acquisition of deferred dividend reinvestment shares under 3M's Compensation Plan for Non-Employee Directors, indicating the transactions are tied to director compensation and plan features rather than open-market trades.
3M director Anne H. Chow reported additional indirect holdings of common stock through a compensation plan. On May 12, 2026, an account associated with her received 1,360.402 shares of 3M common stock at $143.34 per share via deferred dividend reinvestment under 3M's Compensation Plan for Non-Employee Directors. Following this acquisition, indirect holdings in that account totaled 5,129.917 shares, while her separate direct holdings stood at 1,957.242 shares. The filing notes she has no voting or investment power over the common stock equivalents account.
3M director Thomas K. Brown reported routine equity compensation rather than an open-market trade. A corporate entity associated with him acquired 1,360.402 shares of common stock at $143.34 per share as a grant or award under 3M's Compensation Plan for Non-Employee Directors, through deferred dividend reinvestment and deferral of director compensation into a common stock equivalents account. According to the footnotes, he has no voting or investment power over this account. Following the transactions, he holds 1,293.727 shares directly and 17,687.169 shares indirectly through the corporation.
3M director James R. Fitterling reported an equity-based compensation award linked to his non-employee director pay. An indirect account held by a corporation associated with him acquired 1,360.402 shares of 3M common stock at $143.34 per share as a grant or award. Following this, that indirect corporate account held 7,868.463 shares, alongside 11,412.005 directly held shares and 200 shares held indirectly by his spouse. Footnotes explain that the award includes deferred dividend reinvestment shares under 3M's Compensation Plan for Non-Employee Directors and that he has no voting or investment power over the common stock equivalents account.
Bozeman David P reported acquisition or exercise transactions in this Form 4 filing.
3M director David P. Bozeman reported a stock award of 1,360.402 shares of common stock at $143.34 per share. This was classified as a grant or award, so it reflects equity compensation rather than an open‑market purchase.
Following the grant, Bozeman directly holds 1,360.402 common shares. A separate line shows an indirect holding of 1,669.945 common shares held by a corporation, which includes deferred dividend reinvestment shares connected to 3M’s Compensation Plan for Non‑Employee Directors.
3M CO non-employee director Audrey Choi recorded an acquisition of 1,360.402 shares of common stock equivalents as compensation. These were credited at a reference price of $143.34 per share under 3M's Compensation Plan for Non-Employee Directors.
After this grant, the indirect holdings in this account total 6,169.927 common stock equivalents. According to the plan terms, the director has elected to defer compensation into a common stock equivalents account and has no voting or investment powers with respect to this account.